GENE ONLINE|News &
Opinion
Blog

Rare Disease
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
FDA Lifts Hold on LogicBio’s Gene Editing Program
2022-05-10
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
Astellas Reveals Early Safety Data of Gene Therapy for Pompe Disease
2022-02-09
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2022-01-14
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
FDA Greenlights First and Only Treatment for Cholestatic Pruritus with ALGS
2021-10-04
1 2 3
LATEST
Blueprint Medicines Gathers Up To $1.25 Billion in Loans and Investments for Research and Development
2022-07-01
FDA Halts Sanofi’s $3.7B Multiple Sclerosis Investment
2022-07-01
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
Bon Natural Life Limited Announces Change to Board Composition
2022-06-30
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
ReCode Therapeutics’ Secures an Extra $120 Million To Support Its Drug Delivery Platform
2022-06-30
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top